Journal of Cataract & Refractive Surgery
Volume 35, Issue 9 , Pages 1523-1531.e1 , September 2009

Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery

Received 12 February 2009 ,Revised 20 March 2009 ,Accepted 24 March 2009.

References 

  1. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978–988
  2. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:407–410
  3. Seal DV, Barry P, Gettinby G, Lees F, Peterson M, Revie CW, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:396–406
  4. Seal D, Reischl U, Behr A, Ferrer C, Alio J, Koerner , et al. Laboratory diagnosis of endophthalmitis: comparison of microbiology and molecular methods in the European Society of Cataract & Refractive Surgeons multicenter study and susceptibility testing; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2008;34:1439–1450
  5. The Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study; a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–1496
  6. Lalwani GA, Flynn HW, Scott IU, Quinn CM, Berrocal AM, Davis JL, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996–2005); clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008;115:473–476
  7. Wong TY, Chee S-P. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology. 2004;111:699–705
  8. Miller JJ, Scott IU, Flynn HW, Smiddy WE, Corey RP, Miller D. Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol. 2004;138:231–236
  9. Soriano F, Pérez-Trallero E, Pallarés R, Meseguer MA, Fleites A, Gené A, et al. Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options; on behalf of the Spanish Pneumococcal Infection Study Network. Clin Microbiol Infect. 2006;12:519–526
  10. Mao LK, Flynn HW, Miller D, Pflugfelder SC. Endophthalmitis caused by streptococcal species. Arch Ophthalmol. 1992;110:798–801
  11. Miller JJ, Scott IU, Flynn HW, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983–987
  12. Pinna A, Zanetti S, Sotgiu M, Sechi LA, Fadda G, Carta F. Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections. Br J Ophthalmol. 1999;83:771–773
  13. Center KJ, Reboli AC, Hubler R, Rodgers GL, Long SS. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J Clin Microbiol. 2003;41:4660–4665Available at: http://jcm.asm.org/cgi/reprint/41/10/4660Accessed April 18, 2009
  14. Cimiotti JP, Haas JP, Della-Latta P, Wu F, Saiman L, Larson EL. Prevalence and clinical relevance of staphylococcus warneri in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2007;28:326–330
  15. Shimamura Y, Kidokoro S, Murata M. Survey and properties of staphylococcus aureus isolated from Japanese-style desserts. Biosci Biotechnol Biochem. 2006;70:1571–1577Available at: http://www.jstage.jst.go.jp/article/bbb/70/7/1571/_pdfAccessed April 18, 2009
  16. Aaberg TM, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis; a 10-year review of incidence and outcomes. Ophthalmology. 1998;105:1004–1010
  17. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112:1388–1394
  18. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, et al. Acute endophthalmitis following cataract surgery; a systematic review of the literature. Arch Ophthalmol. 2005;123:613–620
  19. Jensen MK, Fiscella RG, Crandall AS, Moshirfar M, Mooney B, Wallin T, et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. 2005;139:141–148
  20. Semmens JB, Li J, Morlet N, Ng J. Trends in cataract surgery and postoperative endophthalmitis in Western Australia (1980-1998): the Endophthalmitis Population Study of Western Australia. Clin Exp Ophthalmol. 2003;31:213–219
  21. Lundström M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery; a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114:866–870
  22. Manners TD, Chitkara DK, Marsh PJ, Stoddart MG. Anterior chamber aspirate cultures in small incision cataract surgery. Br J Ophthalmol. 1995;79:878–880
  23. Beigi B, Westlake W, Mangelschots E, Chang B, Rich W, Riordan T. Peroperative microbial contamination of anterior chamber aspirates during extracapsular cataract extraction and phacoemulsification. Br J Ophthalmol. 1997;81:953–955
  24. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol. 1991;112:278–282
  25. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HF. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol. 2006;124:479–483
  26. Deramo VA, Lai JC, Fastenberg DM, Udell IJ. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol. 2006;142:721–725
  27. Kernt M, Neubauer AS, Ulbig MW, Kampik A, Welge-Lüßen U. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg. 2008;34:480–488
  28. Montan PG, Wejde G, Setterquist H, Rylander M, Zetterström C. Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg. 2002;28:982–987
  29. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28:977–981
  30. Gupta MS, McKee HD, Saldaña M, Stewart OG. Macular thickness after cataract surgery with intracameral cefuroxime. J Cataract Refract Surg. 2005;31:1163–1166

 No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(09)00507-0

doi: 10.1016/j.jcrs.2009.03.049

Journal of Cataract & Refractive Surgery
Volume 35, Issue 9 , Pages 1523-1531.e1 , September 2009